Patents
Patents for C07C 311 - Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups (17,647)
06/2010
06/10/2010US20100144681 Compounds for the treatment of alzheimer's disease
06/09/2010EP2194038A2 Improved preparation of 2S,3S-N-isobutyl-N-(2-hydroxy-3-amino-4-phenylbutyl)-P-nitrobenzenesulfonylamide hydrochloride and other derivatives of 2-hydroxy-1,3-diamines
06/09/2010EP2193117A1 Inhibitors of beta amyloid production
06/09/2010EP0951295B1 Compositions for use in inhibiting of alpha-v-beta3 mediated angiogenesis
06/09/2010CN1910144B Sulfonamide derivatives for the treatment of diseases
06/09/2010CN101723863A Preparation method of purple active dye
06/09/2010CN101723862A Preparation method of wool purple reactive dye
06/03/2010WO2009061652A8 Compounds which modulate the cb2 receptor
06/03/2010US20100137291 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use
06/03/2010CA2744021A1 Nitrooxy cycloalkane derivatives
06/02/2010EP2190814A1 N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors
06/02/2010EP1658263B1 Novel aminobenzophenone compounds
06/02/2010CN101054345B Novel bensophenone derivatives or salts thereof
06/01/2010US7727997 N,N′-substituted-1,3-diamino-2-hydroxypropane derivatives
06/01/2010US7727982 N-(5-bromo-2-pyridinyl)-(2-4-[(2-aminosulfonyl)phenyl]phenylcarbonylamino)phenylcarboxamide; potent and highly selective inhibitors; coagulation disorders; antithrombotic agents; diagnostic reagents; good bioavailability and/or solubility
06/01/2010US7727981 monoamidino-containing compounds having good bioavailability and/or solubility, used as potent and specific inhibitors of blood coagulation in mammals, and as therapeutic agents for disease states characterized by coagulation disorders
05/2010
05/27/2010WO2010057865A1 N- inden- 2 -yl- isopropylsulfonamides as ampa receptor potentiators
05/27/2010WO2006103261A9 Inhibitors of neurotrypsin and determination thereof
05/27/2010US20100130615 Sulfonylurea inhibitors of atp-sensitive potassium channels
05/26/2010EP2189443A1 Tricyclic amide compound
05/26/2010EP2188269A1 New compounds
05/26/2010EP1819668B1 Novel 2-cyano-3-(halo)alkoxy-benzenesulfonamide compounds for combating animal pests
05/26/2010EP1776347B1 Sulphonamide derivatives, their preparation and their therapeutic application
05/26/2010EP1730103B1 Formamide derivatives useful as adrenoceptor
05/26/2010EP1497278B1 Heterocyclic amide derivatives as cytokine inhibitors
05/26/2010CN1922482B Detection cartridges and methods
05/26/2010CN1849117B Entry inhibitors of the HIV virus
05/26/2010CN1809935B Polymer device preparation
05/26/2010CN1391469B Npyy5拮抗剂 Npyy5 antagonist
05/26/2010CN101712640A methods and compositions for treating amyloid-related diseases
05/26/2010CN101712632A Substituted tetracycline compounds
05/25/2010US7723267 Substituted fluoroalcoxyphenylsulfonylurea
05/25/2010CA2415178C 9-substituted minocycline compounds
05/25/2010CA2282917C Pulverulent rubber powders comprising modified fillers, processes for their preparation and their use
05/25/2010CA2248303C Perfluorinated amide salts and their uses as ionic conducting materials
05/20/2010WO2010056527A2 Fused heterocyclic compounds as ion channel modulators
05/20/2010WO2010055887A1 Novel sulfonium salt, method for producing same and use of same
05/20/2010WO2010055005A1 Naphthylacetic acids
05/20/2010WO2009053058A3 Salts of 2-iodo-n-[(4-methoxy-6-methyl-1,3,5-triazine-2-yl)carbamoyl]benzenesulfonamide, method for the production thereof and use thereof as herbicides and plant growth regulators
05/20/2010US20100125090 Modulators of ATP-Binding Cassette Transporters
05/20/2010US20100125076 Substituted sulphonamides, process for their preparation, pharmaceutical composition comprising thereof and their use
05/20/2010US20100124543 Sulphonamide derivatives as prodrugs of aspartyl protease inhibitors
05/20/2010CA2780624A1 Isoprenyl compounds and methods thereof
05/20/2010CA2740864A1 Naphthylacetic acids
05/19/2010EP2186793A1 Substituted Tetracycline Compounds
05/18/2010US7718675 Diamino alcohols and their use as renin inhibitor
05/18/2010US7718646 Cyclohexyl(alkyl)propanolamines, preparation method and pharmaceutical compositions containing same
05/14/2010WO2010051933A2 Substituted sulphonamido phenoxybenzamides
05/13/2010US20100120725 Substituted Phenylsulfonamide Inhibitors of Beta Amyloid Production
05/12/2010CN1939895B Compound, composition and method for preventing from neurodegeneration in injury of central nervous system
05/12/2010CN1602291B Novel bensophenone derivatives or salts thereof
05/12/2010CN101704810A Cycloalkyl inhibitors of potassium channel function
05/12/2010CN101704771A Improved process for producing asulam
05/11/2010US7713963 Acylated indanyl amines and their use as pharmaceuticals
05/11/2010CA2248244C Heterocyclic aromatic anion salts, and their uses as ionic conducting materials
05/06/2010WO2010049946A2 Thyroid receptor ligands
05/06/2010US20100113522 COMPOUNDS FOR THE MODULATION OF PPARgamma ACTIVITY
05/06/2010US20100113449 Fused heterocyclic compounds as ion channel modulators
05/06/2010US20100112455 Solvents and novel electrolytic compositions having a large range of stability and high conductivity
05/06/2010CA2741517A1 Thyroid receptor ligands
05/05/2010EP1891001B1 SULFONAMIDE DERIVATIVES USEFUL AS LIVER CARNITINE PALMITOYL TRANSFERASE (L-CPTl) INHIBITORS
05/05/2010EP1438286B1 Method for producing arylsuphonic acid isocyanates
05/05/2010CN1630629B 酯化合物及其医药用途 Ester compounds and pharmaceutical use
05/05/2010CN1416341B Stable emulsion compositions
05/05/2010CN101701006A Phenethanolamine derivatives for treatment of respiratory diseases
05/04/2010US7709515 Therapy for cardiovascular disorders; dyslipidemia; glucose metabolism disorders; Alzheimer's disease
05/04/2010US7709478 Acylated 6,7,8,9-tetrahydro-5H-benzocycloheptenyl amines and their use as pharmaceutical agents
05/04/2010CA2320467C Cycloalkene derivatives, their production and use
04/2010
04/29/2010WO2010048332A2 Compounds for treating ophthalmic diseases and disorders
04/29/2010WO2008152653A3 An improved process for the preparation of tamsulosin hydrochloride
04/29/2010US20100105905 EP2 Agonists
04/29/2010US20100105894 Cyclopropane compounds and pharmaceutical use thereof
04/29/2010US20100105686 Phenylsulfamoyl benzamide derivatives as bradykinin antagonists
04/29/2010CA2740952A1 Compounds for treating ophthalmic diseases and disorders
04/28/2010CN1795183B Hydroxyamidine and hydroxyguanidine compounds as urokinase inhibitors
04/27/2010CA2345118C Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity
04/27/2010CA2338968C Glucocorticoid-selective agents
04/27/2010CA2301842C Substituted benzene compounds as antiproliferative and cholesterol lowering agents
04/22/2010WO2010044686A1 Akr1c3 as a biomarker, methods of selecting and treating patients based upon an akr1c3 profile and compounds for use therein
04/22/2010WO2010044685A1 Nitrophenyl mustard alcohols, their corresponding phosphates and their use as targeted cytotoxic agents
04/22/2010WO2010043000A1 S1p receptors modulators and their use thereof
04/22/2010WO2010018113A3 Bi-aryl aminotetralines
04/22/2010WO2010018112A3 Monoaryl aminotetralines
04/22/2010US20100096590 Novel liquid crystal compound containing sulfone group, liquid crystal composition comprising the same, and optical film using the same liquid crystal composition
04/22/2010CA2740484A1 S1p receptors modulators and their use thereof
04/21/2010EP2177506A1 Positive resist composition, pattern forming method using the composition, and compound used in the composition
04/21/2010EP2176210A1 Degradation accelerator for polymers and polymer article comprising it
04/21/2010EP1272175B1 N,n'-diaryl guanidines as il-8 receptor antagonists
04/20/2010US7700654 isolating a substance having antiandrogenic activity from the bark of the African plum tree P. africana, and synthesising structural variants of these substances; even able to inhibit the growth of prostate cancer cells that do not respond to treatment with hydroxyflutamide
04/20/2010US7700637 Organic compounds
04/20/2010US7700586 Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders
04/20/2010CA2418744C Novel aminocyclohexane derivatives
04/15/2010WO2010041748A1 Fluorene compound and use thereof for medical purposes
04/15/2010WO2009148600A3 Deuterated lysine-based compounds
04/15/2010WO2009113704A3 Fluorine-containing compound and method for detecting biomolecule using the same
04/15/2010US20100094052 Process for preparing acylsulfamoylbenzamides
04/15/2010US20100093865 Sulphur-linked compounds for treating ophthalmic diseases and disorders
04/15/2010US20100093811 Hiv protease inhibitors
04/15/2010US20100093802 Ccr9 inhibitors and methods of use thereof
04/15/2010US20100093708 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use
1 ... 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 ... 177